www.jobs4dd.com
United BioSource Corporation (UBC, Bethesda, Maryland) has acquired Caro Research, which provides simulation technologies to assess healthcare costs and benefits; and an ownership interest in ClinResearch, which offers technology and services for adaptive clinical trials.
Terms of the deals were not disclosed. Caro Research, headquartered in Concord, Massachusetts, was founded by Dr Jaime Caro in 1993. It provides complex modelling techniques, including discrete event simulation, and has an extensive knowledge of cost data sources and population databases. Dr Caro will join UBC as director of its health economics services. The acquisition will expand the company’s presence in the European, Canadian and Latin American markets.
ClinResearch, which will now operate under the name UBC ClinResearch, is headquartered in Cologne, Germany, and has around 100 employees. The company has designed and implemented 80 adaptive trial programmes over the past seven years. Its co-founder, Reinhard Eisebitt, is a co-developer of the leading software used by pharmaceutical companies and contract research organisations to support the rigorous statistical requirements of adaptive trials.
"The interest in adaptive design is accelerating from the early adopter to the rapid growth stage,” noted Dr Michael Fischer, co-founder of ClinResearch. “We … anticipate growth in Cologne, as well as in our offices in Russia and the Ukraine.”
The acquisitions are the latest in a series of transactions made since UBC raised $153 million in equity capital from a syndicate of private equity firms in 2003. Article submitted by www.jobs4dd.com
Photo:
http://www.prlog.org/
